O'NEIL PATRICK R. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

O'NEIL PATRICK R. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $16.03M.

Profile

O'NEIL PATRICK R.

Patrick R. O'Neil serves as the Executive Vice President, Chief Legal Officer, and General Counsel at Ionis Pharmaceuticals, a leader in antisense technology for drug development. He has been involved in the company through various SEC filings, indicating a significant role in its legal and corporate governance.

RoleEVP CLO & General Counsel
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-30IONSIONIS PHARMACEUTICALS INCS — Open-market sale3.1K$80.00$246K
2026-03-11IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]10.1K$75.25$764K
2026-03-03IONSIONIS PHARMACEUTICALS INCJ — Other acquisition / disposition376$48.87$18K
2026-02-03IONSIONIS PHARMACEUTICALS INCS — Open-market sale6.2K$83.53$516K
2026-02-03IONSIONIS PHARMACEUTICALS INCA — Grant or award12.0K$0.00
2026-01-21IONSIONIS PHARMACEUTICALS INCS — Open-market sale9.2K$75.84$697K
2026-01-21IONSIONIS PHARMACEUTICALS INCM — Option exercise21.5K$0.00
2025-10-06IONSIONIS PHARMACEUTICALS INCS — Open-market sale3.2K$69.27$224K
2025-10-06IONSIONIS PHARMACEUTICALS INCS — Open-market sale10.2K$69.89$713K
2025-10-06IONSIONIS PHARMACEUTICALS INCM — Option exercise10.2K$52.87$539K
2025-10-02IONSIONIS PHARMACEUTICALS INCS — Open-market sale34.5K$67.69$2.33M
2025-10-02IONSIONIS PHARMACEUTICALS INCM — Option exercise34.5K$60.89$2.10M
2025-10-02IONSIONIS PHARMACEUTICALS INCS — Open-market sale30.2K$67.69$2.04M
2025-10-02IONSIONIS PHARMACEUTICALS INCM — Option exercise30.2K$56.78$1.71M
2025-09-29IONSIONIS PHARMACEUTICALS INCS — Open-market sale14.8K$64.68$959K
2025-09-29IONSIONIS PHARMACEUTICALS INCM — Option exercise14.8K$56.78$842K
2025-09-29IONSIONIS PHARMACEUTICALS INCS — Open-market sale10.5K$64.54$676K
2025-09-29IONSIONIS PHARMACEUTICALS INCM — Option exercise10.5K$56.78$595K
2025-09-12IONSIONIS PHARMACEUTICALS INCS — Open-market sale1.7K$64.58$110K
2025-09-12IONSIONIS PHARMACEUTICALS INCM — Option exercise1.7K$56.78$97K

Companies — Last 90 Days

Frequently Asked Questions

Who is O'NEIL PATRICK R.?

Patrick R. O'Neil serves as the Executive Vice President, Chief Legal Officer, and General Counsel at Ionis Pharmaceuticals, a leader in antisense technology for drug development. He has been involved in the company through various SEC filings, indicating a significant role in its legal and corporate governance.…

How many SEC Form 4 filings has O'NEIL PATRICK R. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has O'NEIL PATRICK R. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 16 open-market sales ($16.03M) across all tracked filings.

Where can I see all of O'NEIL PATRICK R.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live O'NEIL PATRICK R. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.